ArticleAdvanced healthcare materials2026
Muscle-Conformal Injectable Eutectogel Platform With Activated Adhesion for Therapeutic Epidermal Bioelectronics.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Achieving simultaneous wet adhesion, mechanical robustness, and long-term ionic conductivity in soft electronic interfaces remains a major challenge for the design of next-generation epidermal bioelectronics. Here, an injectable, muscle-conformal eutectogel comprising gelatin-based microgels and a polymerizable ternary eutectic solvent ([PTES]) is introduced, serving as a reactive medium and catalyst for rapid epoxy-amine crosslinking at physiological temperature. The [PTES] system establishes an extended hydrogen-bonding and ionic network that accelerates ring-opening reactions, enabling fast on-tissue gelation and robust adhesion. Compositional tuning reveals that increasing [PTES] content enhances complex viscosity by 114%, increases peel adhesion from 0.238 ± 0.063 to 0.309 ± 0.091·Nm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.